Averin, Ahuva
Silvia, Amanda
Lamerato, Lois
Richert-Boe, Kathryn
Kaur, Manpreet
Sundaresan, Devi
Shah, Neel
Hatfield, Mark
Lawrence, Tatiana
Lyman, Gary H.
Weycker, Derek
Funding for this research was provided by:
Amgen Inc.
Article History
Received: 2 July 2020
Accepted: 21 August 2020
First Online: 3 September 2020
Compliance with ethical standards
:
: AA is employed by Policy Analysis Inc., which received funding for this research from Amgen Inc.AS is employed by Policy Analysis Inc., which received funding for this research from Amgen Inc.LL reports grants from Policy Analysis Inc.KR-B is employed by Kaiser Permanente Northwest Region, Portland, OR, which received study funding from Amgen Inc.MK has nothing to disclose.DS has nothing to disclose.NS is an employee of and owns stock in Amgen.MH is an employee of and owns stock in Amgen.TL is an employee of and owns stock in Amgen.GHL reports serving as a consultant for Agendia, Amgen, Genomic Health, Halozyme Therapeutics, Mylan, Partners HealthCare, Pfizer, Samsung Bioepis, and Spectrum Pharmaceuticals.DW is employed by Policy Analysis Inc., which received funding for this research from Amgen Inc.
: The study was approved by the institutional review boards of Geisinger Health System, Henry Ford Health System, Kaiser Permanente Northwest, and Reliant Medical Group.
: Not applicable for this retrospective study.
: Not applicable.